Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
ADC Therapeutics SA
organization3 mentionslast seen Nov 4, 2026
Commercial-stage biopharmaceutical company and leader in antibody drug conjugates.
Relationships 18
- ADC Therapeutics SAdevelopsZYNLONTA99% confidence3 sources
- ADC Therapeutics SAemploysAmeet Mallik99% confidence2 sources
- ADC Therapeutics SAemploysPeter J. Graham99% confidence2 sources
- ADC Therapeutics SAfunded bySeries B Preferred Stock Private Placement95% confidence1 source
- ADC Therapeutics SAfunded byHealthcare Royalty Management, LLC95% confidence1 source
- Bain Capital Life Sciencesinvests inADC Therapeutics SA95% confidence1 source
- TCG Crossover Fund II, L.P.invests inADC Therapeutics SA95% confidence1 source
- Redmileinvests inADC Therapeutics SA95% confidence1 source
- Nantahala Capitalinvests inADC Therapeutics SA95% confidence1 source
- ADC Therapeutics SAemploysMohamed Zaki95% confidence1 source
- ADC Therapeutics SAcommercializesZYNLONTA90% confidence1 source
- ADC Therapeutics SAdevelopsantibody-drug conjugate85% confidence1 source
- Bain Capital Life Sciencesinvests inADC Therapeutics SA85% confidence1 source
- Redmileinvests inADC Therapeutics SA85% confidence1 source
- TCG Crossover Fund II, L.P.invests inADC Therapeutics SA85% confidence1 source
- Nantahala Capitalinvests inADC Therapeutics SA85% confidence1 source
- Tanabe Pharma Corporationpartners withADC Therapeutics SA80% confidence1 source
- Nippon Shinyakupartners withADC Therapeutics SA80% confidence1 source
Relationship
ADC Therapeutics SAdevelopsZYNLONTA
99% confidence3 supporting mentions
Either name opens that entity’s relationships.
Sources 3
- filingSEC EDGARNov 4, 2026ADC Therapeutics SA 8-K: Item 2.02: Results of Operations and Financial Condition; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced new and updated data from the ZYNLONTA ® clinical program
- newsPR NewswireNov 2, 2026ADC Therapeutics Announces New Employee Inducement Grant
ZYNLONTA® (loncastuximab tesirine-lpyl)
- filingSEC EDGAROct 13, 2026ADC Therapeutics SA 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.02: Results of Operations and Financial Condition; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA ® (loncastuximab tesirine-lpyl)